Fri, July 29, 2011
Thu, July 28, 2011
Wed, July 27, 2011

MRX, BEE, BBOX, BOOM, CVLT, NKTR Expected To Be Up Before Next Earnings Releases


//stocks-investing.news-articles.net/content/201 .. cted-to-be-up-before-next-earnings-releases.html
Published in Stocks and Investing on Thursday, July 28th 2011 at 7:00 GMT by WOPRAI   Print publication without navigation


July 28, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX), STRATEGIC HOTELS & RESORTS I (NYSE:BEE), BLACK BOX CORP (NASDAQ:BBOX), DYNAMIC MATERIALS CORP (NASDAQ:BOOM), COMMVAULT SYSTEMS INC (NASDAQ:CVLT), NEKTAR THERAPEUTICS (NASDAQ:NKTR) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Date
     MRX        MEDICIS PHARMACEUTICAL-CL A         6 Quarter               Q2          08/04/2011
     BEE        STRATEGIC HOTELS & RESORTS I        August Earnings         Q2          08/03/2011
     BBOX       BLACK BOX CORP                      12 Quarter              Q1          08/02/2011
     BOOM       DYNAMIC MATERIALS CORP              August Earnings         Q2          08/02/2011
     CVLT       COMMVAULT SYSTEMS INC               12 Quarter              Q1          08/02/2011
     NKTR       NEKTAR THERAPEUTICS                 August Earnings         Q2          08/04/2011
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

MEDICIS PHARMACEUTICAL-CL A (NYSE:MRX) - Medicis Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. The companys products address various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis, and cosmesis. Its primary products include DYSPORT for temporary improvement in the appearance of glabellar lines in adults younger than 65 years of age; LIPOSONIX to destroy targeted fat just beneath the skin in the treatment of the anterior abdomen; PERLANE and RESTYLANE for the correction of facial wrinkles and folds, such as nasolabial folds; SOLODYN for the treatment of inflammatory lesions of non-nodular acne vulgaris in patients 12 years of age and older; TRIAZ for the topical treatment of acne vulgaris; VANOS, a topical corticosteroid for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older; and ZIANA, a topical treatment of acne vulgaris in patients 12 years of age and older. The company sells its products primarily to wholesale pharmaceutical distributors and retail pharmacy chains. It has strategic collaborations with Glenmark; Revance Therapeutics, Inc.; Hyperion Therapeutics, Inc.; Perrigo Israel Pharmaceuticals Ltd.; and IMPAX Laboratories, Inc. The company was founded in 1987 and is headquartered in Scottsdale, Arizona.

STRATEGIC HOTELS & RESORTS I (NYSE:BEE) - Strategic Hotels & Resorts, Inc., a self-administered and self-managed real estate investment trust (REIT), engages in the ownership and asset management of upper upscale and luxury hotels in North America and Europe. It owns the fee interest in 11 hotels, comprising approximately 4,961 rooms, located in Arizona, California, Florida, Illinois, and Louisiana, and in Mexico; owns leasehold interests in hotels in Illinois, France, and Germany comprising an aggregate of approximately 859 rooms; owns a 35% interest in a hotel in Prague, Czech Republic comprising approximately 372 rooms; owns an 85% interest in each of the InterContinental Hotel in Miami and the InterContinental Hotel in Chicago; and a 31% interest in and act as asset manager for a joint venture that is developing the Four Seasons Residence Club Punta Mita, a luxury vacation home product. The company also manages seven hotels. The company operates hotels under the brands of Embassy Suites, Four Seasons, Hilton, Hyatt, InterContinental, Loews, Marriott, and Ritz-Carlton. The company qualifies as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to the federal income tax if it distributes 100% of its annual taxable income to its shareholders. Strategic Hotel was co-founded by Laurence Geller in 1997 and is headquartered in Chicago, Illinois.

BLACK BOX CORP (NASDAQ:BBOX) - Black Box Corporation provides network infrastructure services for communication systems. The company offers design, installation, integration, monitoring, and maintenance of voice, data, and integrated communication systems. It also provides voice solutions, premise cabling, and other data-related services and products, as well as offers technical support for its solutions that include hotline services, consultation, site surveys, design and engineering, project management, single-site and multi-site installations, remote monitoring, and certification and maintenance of voice, data, and integrated communication solutions. The company serves small organizations, corporations, and institutions. Black Box sells its products and services through catalog, Internet Website, and on-site services offices worldwide. The company was founded in 1973 and is headquartered in Lawrence, Pennsylvania.

DYNAMIC MATERIALS CORP (NASDAQ:BOOM) - Dynamic Materials Corp. provides explosion-welded clad metal plates and welding services. It operates in two segments: Explosive Metalworking and amk Welding. The Explosive Metalworking segment offers clad metal plates for upstream oil and gas, oil refinery, chemical and petrochemical, hydrometallurgy, aluminum production, shipbuilding, power generation, and industrial refrigeration. The amk Welding segment provides services principally to power turbine manufacturers and commercial and military aircraft engine manufacturers. Founded as Explosive Fabricators Inc. in 1965, the company changed its name to Dynamic Materials in 1994. It is headquartered in Boulder, Colo.

COMMVAULT SYSTEMS INC (NASDAQ:CVLT) - CommVault Systems, Inc., together with its subsidiaries, provides data and information management software applications and related services primarily in North America, Europe, Australia, and Asia. The company develops, markets, and sells a suite of software applications and services under the Simpana brand. Its Simpana software suite includes solution for the backup and restoration of enterprise data for file systems, applications, databases, and virtual machine systems; and enterprise-wide compliance and e-discovery with solutions for email, collaboration, file system, and NAS data. The company also provides application module for the protection of applications and remote office data with snapshots and real-time replication; solutions to monitor storage utilization, data growth, operational costs, and service-level attainment; and solutions to search, sort, select, and retrieve corporate files and information from online, archive, and backup data copies. In addition, it offers assessment and design, implementation and post-deployment, training, and customer support services. The company markets and sells its software applications and related services to large enterprises, small and medium sized businesses, and government agencies through value-added resellers, systems integrators, corporate resellers, and original equipment manufacturer partners. It licenses its software applications to customers in various industries, including banking, insurance and financial services, government, healthcare, pharmaceuticals and medical services, technology, legal, manufacturing, utilities, and energy. The company has strategic relationships with Dell, Inc.; Hitachi Data Systems; McAfee, Inc.; and Microsoft Corporation. CommVault Systems was incorporated in 1996 and is headquartered in Oceanport, New Jersey.

NEKTAR THERAPEUTICS (NASDAQ:NKTR) - Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The companys product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The companys proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinical trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Francisco, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641


Publication Contributing Sources